▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁A 3.984375
▁more 5.7109375
▁manage 9.0
able 0.0037384033203125
▁and 2.244140625
▁sa 2.283203125
fer 7.963180541992188e-05
▁alternative 1.666015625
▁might 6.4140625
▁be 0.1898193359375
▁medical 2.681640625
▁mar 0.178466796875
iju 0.0036640167236328125
ana 0.0005488395690917969
. 1.5126953125
▁However 2.90625
, 0.00722503662109375
▁the 1.5947265625
▁legal 4.23828125
▁status 1.1962890625
▁and 2.75390625
▁novel 9.140625
ty 0.6630859375
▁of 0.210205078125
▁this 1.689453125
▁drug 2.091796875
▁do 5.02734375
▁not 0.0703125
▁allow 1.029296875
▁finding 8.7578125
▁a 2.337890625
▁large 4.3828125
▁number 1.4384765625
▁of 0.0037708282470703125
▁studies 1.3291015625
▁on 1.5361328125
▁its 0.98193359375
▁effect 2.060546875
iveness 0.437255859375
. 0.9619140625
▁Specifically 8.1953125
, 0.11529541015625
▁it 2.73046875
▁concerns 4.8359375
▁the 0.64697265625
▁emot 7.37109375
ional 0.01727294921875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.71875
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.1298828125
ic 0.0023956298828125
▁pain 0.0987548828125
. 0.65380859375
▁This 3.150390625
▁research 2.99609375
▁paper 6.21484375
▁a 2.185546875
ims 0.0004074573516845703
▁to 0.0924072265625
▁analyze 3.06640625
▁levels 9.6640625
▁of 0.0341796875
▁de 0.54736328125
pression 0.03619384765625
▁and 0.26953125
▁anx 0.042236328125
iety 0.0012140274047851562
▁among 0.798828125
▁people 3.26171875
▁receiving 0.94482421875
▁ther 8.0078125
apy 0.33935546875
▁by 5.26171875
▁comparing 7.94921875
▁the 0.9873046875
▁effects 2.169921875
▁of 0.0303192138671875
▁ph 2.455078125
arma 0.039642333984375
ce 0.0011568069458007812
ut 7.176399230957031e-05
ical 0.00390625
▁op 0.305419921875
io 0.162841796875
ids 0.058685302734375
▁and 0.275390625
▁MM 1.2138671875
. 1.0
<0x0A> 1.0068359375
The 1.3349609375
▁study 2.015625
▁was 2.06640625
▁conducted 0.7421875
▁in 1.529296875
▁the 1.4443359375
▁form 2.197265625
▁of 0.006374359130859375
▁collect 9.2421875
io 11.4375
N 4.953125
▁and 3.8359375
▁analysis 2.5625
▁of 0.1795654296875
▁statistical 5.1328125
▁data 0.2076416015625
. 0.78173828125
▁Part 5.046875
ic 6.63671875
I 3.263671875
p 1.02734375
ants 0.58349609375
▁were 1.0751953125
▁rec 3.47265625
ru 0.0251312255859375
ited 0.009429931640625
▁for 3.466796875
▁six 7.85546875
▁month 4.984375
S 11.109375
▁at 4.48046875
▁two 2.568359375
▁major 5.546875
▁pain 2.97265625
▁relief 5.046875
▁cent 1.26953125
ers 0.08966064453125
▁in 0.76123046875
▁Israel 4.5546875
. 0.41650390625
▁The 1.3095703125
▁research 2.45703125
ers 1.4970703125
▁used 2.73046875
▁The 7.7421875
▁De 4.41796875
pression 0.030120849609375
▁Module 9.6953125
▁of 0.9091796875
▁the 0.293701171875
▁Pat 2.28515625
ient 0.0124664306640625
▁Health 0.08636474609375
▁Question 0.028106689453125
naire 0.0506591796875
▁and 3.517578125
▁the 0.73046875
▁General 1.888671875
ized 0.73095703125
▁An 0.0233001708984375
x 0.00495147705078125
iety 0.007587432861328125
▁Dis 0.5419921875
order 0.06146240234375
▁Sc 1.2919921875
ale 0.1319580078125
▁to 1.6923828125
▁interview 7.2890625
▁participants 1.814453125
, 3.796875
▁evaluate 5.453125
▁their 0.775390625
▁answers 6.65625
, 0.91259765625
▁and 0.180908203125
▁conduct 4.48046875
▁the 2.158203125
▁study 2.470703125
. 0.23583984375
▁To 5.16796875
▁specifically 10.078125
▁evaluate 2.525390625
▁and 4.421875
▁compare 0.95654296875
▁the 0.350341796875
▁prob 10.9609375
abilities 0.7216796875
▁of 0.132568359375
▁de 0.87255859375
pression 0.04705810546875
▁or 4.515625
▁anx 0.04315185546875
iety 0.00431060791015625
▁among 1.6943359375
▁the 2.275390625
▁diverse 8.8984375
▁groups 1.67578125
, 1.4755859375
▁the 1.0205078125
▁study 2.72265625
▁used 1.6572265625
▁multiple 4.6171875
▁Log 8.2890625
istic 0.138671875
▁regression 1.8798828125
▁analysis 1.041015625
▁and 2.5234375
▁chose 8.7109375
▁medical 7.8203125
▁mar 0.372314453125
iju 0.01044464111328125
ana 0.006481170654296875
▁as 0.85595703125
▁the 1.0537109375
▁control 2.705078125
▁group 0.62744140625
. 0.319091796875
<0x0A> 0.84716796875
This 3.53515625
▁type 6.19140625
▁of 0.01226806640625
▁study 1.74609375
▁is 1.21875
▁the 3.392578125
▁most 1.8896484375
▁reve 8.984375
aling 0.0141754150390625
▁and 1.0341796875
▁inclus 6.42578125
ive 0.00582122802734375
, 2.275390625
▁as 1.869140625
▁it 0.353515625
▁contains 4.95703125
▁direct 6.3984375
▁responses 4.765625
▁from 0.86474609375
▁a 3.87890625
▁l 9.40625
Ar 4.73046875
ge 0.86279296875
▁number 1.115234375
▁of 0.016998291015625
▁participants 1.3056640625
. 0.6337890625
▁All 4.81640625
▁tools 9.2109375
▁in 4.4140625
▁the 0.71826171875
▁form 3.615234375
▁of 0.06158447265625
▁question 1.9560546875
na 0.049407958984375
ires 0.0057373046875
▁and 1.9990234375
▁scales 3.072265625
▁have 3.73046875
▁already 4.40234375
▁been 0.14453125
▁used 1.9619140625
▁and 2.109375
▁proved 4.16015625
▁their 2.0
▁effic 3.42578125
acy 0.0012302398681640625
▁for 3.578125
▁collect 4.875
ing 0.10736083984375
▁analyt 8.2109375
ical 0.324951171875
▁data 0.27734375
. 0.466796875
▁It 3.494140625
▁helps 4.86328125
▁to 0.9658203125
▁system 7.265625
at 1.0244140625
ize 0.033935546875
▁and 1.578125
▁class 4.05859375
ify 0.0102691650390625
▁distinct 9.328125
▁kinds 6.0859375
▁of 0.0289154052734375
▁information 3.453125
▁for 3.953125
▁subsequent 4.1953125
▁un 7.8046875
comp 6.0859375
licated 0.06402587890625
▁services 11.71875
. 0.68310546875
▁Thus 4.4375
, 0.03216552734375
▁research 4.49609375
ers 0.54345703125
▁can 1.3017578125
▁compare 3.892578125
▁the 0.9755859375
▁effects 3.04296875
▁of 0.1072998046875
▁medic 4.44921875
ations 0.94482421875
▁on 1.8271484375
▁patients 2.1171875
▁of 4.484375
▁diverse 3.931640625
▁age 2.68359375
▁groups 0.61083984375
, 0.93798828125
▁background 4.98828125
s 0.218505859375
, 0.08526611328125
▁physical 5.37890625
▁conditions 1.384765625
, 0.105712890625
▁emot 5.3671875
ional 0.0802001953125
▁states 1.380859375
, 0.12030029296875
▁and 0.45849609375
▁so 3.1875
▁on 0.33251953125
. 0.0888671875
<0x0A> 0.73681640625
The 1.1181640625
▁analysis 4.66015625
▁of 0.548828125
▁any 8.84375
▁human 6.15625
▁reaction 4.7109375
▁has 4.53515625
▁a 1.787109375
▁high 4.4375
▁potential 3.337890625
▁of 1.615234375
▁subject 6.25
iveness 3.8671875
▁and 1.322265625
▁bias 2.2109375
, 1.8623046875
▁especially 2.482421875
▁regarding 4.34765625
▁people 4.5078125
▁in 3.990234375
▁severe 4.46875
▁pain 0.312255859375
▁and 2.650390625
▁un 5.39453125
stable 1.8486328125
▁emot 0.859375
ional 0.1859130859375
▁condition 2.453125
. 0.0732421875
▁Perhaps 8.921875
▁some 5.125
▁patients 2.3203125
▁tend 5.453125
▁to 0.022979736328125
▁ex 2.611328125
agger 0.0027637481689453125
ate 0.007534027099609375
▁their 0.7138671875
▁de 5.046875
press 1.515625
ive 0.33349609375
▁state 3.095703125
▁or 1.8564453125
▁vice 7.44921875
▁vers 0.0281829833984375
a 0.01421356201171875
, 1.0419921875
▁de 7.58984375
- 4.171875
emph 0.96142578125
as 0.01224517822265625
ize 0.14404296875
▁serious 6.61328125
▁difficulties 6.00390625
. 0.89111328125
▁Because 6.14453125
▁the 2.28515625
▁survey 6.046875
▁responses 6.59765625
▁were 1.607421875
▁thoroughly 7.93359375
▁anonymous 5.29296875
, 0.45751953125
▁the 1.4375
▁research 1.5166015625
ers 0.26513671875
▁were 1.455078125
▁unable 2.392578125
▁to 0.005992889404296875
▁carefully 8.6796875
▁analyze 1.556640625
▁each 3.958984375
▁patient 2.505859375
’ 26.46875
s 0.487548828125
▁reaction 3.73046875
▁and 2.375
▁compare 3.47265625
▁it 0.93017578125
▁to 1.23046875
▁the 0.7724609375
▁actual 5.484375
▁states 7.27734375
▁of 0.76171875
▁condition 7.02734375
. 0.348876953125
▁More 6.8203125
▁accurate 3.953125
▁answers 4.671875
▁could 2.427734375
▁be 0.9052734375
▁obtained 0.98095703125
▁by 1.3505859375
▁professional 7.6015625
▁psych 2.3125
olog 0.34619140625
ists 0.006549835205078125
▁via 7.97265625
▁pe 11.546875
R 2.9296875
son 0.6875
al 0.288818359375
▁communication 6.046875
▁and 1.890625
▁behavior 6.69921875
al 0.37548828125
▁analysis 2.046875
. 0.2318115234375
▁However 2.837890625
, 0.003643035888671875
▁this 1.9140625
▁method 2.71484375
▁of 2.470703125
▁research 2.02734375
▁is 0.87158203125
▁way 7.6875
▁more 1.591796875
▁resource 6.6796875
- 0.43798828125
int 0.603515625
ensive 0.011993408203125
▁and 0.5888671875
▁energy 8.7265625
- 0.1383056640625
consum 0.31005859375
ing 0.0055694580078125
. 0.5751953125
<0x0A> 0.66357421875
Part 5.375
icip 0.15380859375
ants 0.12451171875
▁were 1.0224609375
▁rec 1.6318359375
ru 0.0048065185546875
ited 0.0016527175903320312
▁for 1.3515625
▁six 1.8544921875
▁months 0.64453125
▁at 0.72998046875
▁two 0.2386474609375
▁Major 7.875
▁pain 1.11328125
▁relief 0.0958251953125
▁cent 0.18017578125
ers 0.0244140625
▁in 0.138916015625
▁Israel 0.06500244140625
. 0.266845703125
▁All 3.466796875
▁patients 1.64453125
▁experienced 5.11328125
▁chron 1.798828125
ic 0.0042724609375
▁pain 0.11480712890625
▁for 3.271484375
▁at 0.763671875
▁least 0.00362396240234375
▁ 0.96240234375
3 1.4033203125
▁months 0.230712890625
. 0.9658203125
▁The 1.490234375
▁study 1.9921875
▁included 2.19140625
▁ 1.1015625
8 2.892578125
9 2.80859375
0 3.693359375
▁participants 1.3359375
, 1.322265625
▁of 1.7724609375
▁which 0.37548828125
▁ 0.1573486328125
4 1.62109375
7 2.451171875
4 2.75
▁( 2.189453125
5 0.104248046875
9 11.0703125
%) 0.93896484375
▁were 0.485595703125
▁treated 4.64453125
▁sole 6.9453125
ly 0.0006957054138183594
▁with 0.478271484375
▁op 0.89013671875
io 0.429443359375
ids 0.206787109375
, 1.12890625
▁ 0.60595703125
3 1.1044921875
2 2.123046875
9 2.548828125
▁( 0.048065185546875
4 1.13671875
1 1.24609375
%) 0.1402587890625
▁were 1.298828125
▁treated 0.51123046875
▁with 0.1925048828125
▁MM 0.88232421875
, 0.277587890625
▁and 0.168701171875
▁ 0.1497802734375
7 3.15234375
7 2.41015625
▁( 0.2017822265625
8 3.861328125
. 1.2099609375
6 2.921875
%) 0.061309814453125
▁acquired 9.6015625
▁both 1.083984375
▁( 6.8984375
Fe 10.0078125
ing 4.07421875
old 0.0234527587890625
▁et 1.4541015625
▁al 0.0311279296875
., 0.301025390625
▁ 0.01343536376953125
2 0.1966552734375
0 0.0011663436889648438
1 0.44921875
7 2.126953125
). 0.1541748046875
▁The 1.33984375
▁remaining 7.05859375
▁ten 8.1796875
▁participants 1.3447265625
▁who 5.5390625
▁did 1.4736328125
▁not 0.00910186767578125
▁receive 1.884765625
▁ph 3.10546875
arma 0.054473876953125
ce 0.0029811859130859375
ut 0.0015497207641601562
ical 0.00362396240234375
▁op 0.93603515625
io 0.096435546875
ids 0.0268707275390625
▁and 1.712890625
▁medical 2.36328125
▁mar 0.0589599609375
iju 0.01023101806640625
ana 0.00046372413635253906
▁were 1.3046875
▁with 6.078125
dra 0.2008056640625
wn 0.0014486312866210938
▁from 0.27099609375
▁the 0.107666015625
▁analysis 4.5546875
▁in 4.91796875
▁the 1.23828125
▁research 4.34765625
. 0.7509765625
▁Therefore 4.9140625
, 0.0094146728515625
▁it 3.759765625
▁is 0.896484375
▁not 2.75
▁possible 0.6943359375
▁to 0.0222320556640625
▁compreh 6.53125
ens 0.06182861328125
ively 0.01654052734375
▁compare 1.8984375
▁patients 4.828125
▁taking 4.26953125
▁medic 3.822265625
ations 0.427734375
▁with 0.9638671875
▁those 1.181640625
▁who 1.1396484375
▁do 1.7021484375
▁not 0.0098114013671875
. 0.81982421875
<0x0A> 0.638671875
The 1.10546875
▁study 1.732421875
▁conducted 4.73828125
▁a 2.052734375
▁correlation 6.49609375
▁type 7.359375
▁of 0.47021484375
▁research 1.9130859375
▁with 2.892578125
▁variable 8.03125
▁measures 4.53125
. 1.2802734375
▁It 2.142578125
▁evaluated 4.39453125
▁the 0.5673828125
▁inter 6.20703125
dep 3.078125
end 0.005191802978515625
ence 0.0130462646484375
▁of 0.5712890625
▁various 3.884765625
▁factors 1.66796875
▁that 2.837890625
▁affected 4.1171875
▁the 0.5908203125
▁physical 6.8359375
▁and 0.97314453125
▁emot 0.456298828125
ional 0.0006508827209472656
▁condition 1.0166015625
▁of 0.11663818359375
▁patients 0.65869140625
▁experien 4.17578125
cing 0.0005745887756347656
▁chron 0.59619140625
ic 0.0008463859558105469
▁pain 0.030120849609375
. 0.220703125
▁For 3.876953125
▁example 1.15625
, 0.018463134765625
▁the 1.1826171875
▁survey 5.078125
▁showed 3.423828125
▁that 0.419189453125
▁the 1.734375
▁ratio 6.93359375
▁of 0.138671875
▁female 4.5078125
▁patients 0.84033203125
▁was 1.8603515625
▁remark 9.453125
ably 0.0023822784423828125
▁higher 0.52392578125
▁in 2.7265625
▁the 0.97607421875
▁op 4.76953125
i 3.71484375
ates 0.1478271484375
▁group 0.283935546875
▁compared 2.83203125
▁to 0.12042236328125
▁the 0.51123046875
▁MM 0.53076171875
▁group 0.29345703125
. 0.479248046875
▁In 3.0
▁turn 4.06640625
, 0.0036678314208984375
▁people 5.875
▁on 5.453125
▁op 1.4423828125
i 0.45947265625
ates 0.0053558349609375
▁were 1.0595703125
▁more 0.9892578125
▁likely 0.38427734375
▁to 0.06146240234375
▁report 3.150390625
▁major 5.96484375
▁de 0.325927734375
press 1.21875
ive 0.00542449951171875
▁dis 0.5078125
orders 1.455078125
. 1.7900390625
<0x0A> 2.58984375
The 1.109375
▁question 5.56640625
na 1.1396484375
ires 0.0009703636169433594
▁used 2.001953125
▁different 8.4140625
▁variable 8.53125
▁measures 0.78515625
▁to 1.3525390625
▁collect 2.513671875
▁information 1.982421875
. 1.6025390625
▁For 1.98828125
▁example 0.216064453125
, 0.00930023193359375
▁it 4.078125
▁included 2.447265625
▁compreh 8.7734375
ensive 0.0283966064453125
▁so 6.91796875
cio 0.03240966796875
- 0.363525390625
dem 0.099365234375
ographic 0.0439453125
▁data 1.0478515625
: 4.7890625
▁gender 1.580078125
, 0.09808349609375
▁age 0.2171630859375
, 0.0931396484375
▁country 4.39453125
, 1.4580078125
▁type 4.390625
▁of 0.0625
▁residence 3.80078125
▁( 3.490234375
urban 2.123046875
/ 2.826171875
r 0.068359375
ural 0.0016765594482421875
), 0.2388916015625
▁years 6.00390625
▁of 0.1668701171875
▁education 0.67236328125
, 0.1519775390625
▁and 1.873046875
▁employ 3.640625
ment 0.00579071044921875
▁status 0.443359375
. 0.1756591796875
▁Pat 4.0703125
ients 0.09149169921875
▁were 1.1767578125
▁also 0.861328125
▁asked 0.58642578125
▁about 1.19921875
▁their 0.6015625
▁medical 2.751953125
▁history 0.421875
▁over 8.8359375
▁the 0.1724853515625
▁years 3.98828125
▁and 1.802734375
▁the 1.845703125
▁current 3.34765625
▁presence 5.859375
▁of 0.05450439453125
▁any 2.650390625
▁severe 4.59765625
▁dise 1.5390625
ases 0.0003223419189453125
▁such 4.16015625
▁as 0.0049896240234375
▁heart 2.408203125
▁failure 2.05078125
, 0.1837158203125
▁di 1.865234375
ab 0.002773284912109375
etes 0.0050201416015625
, 0.12457275390625
▁ar 3.787109375
th 0.118408203125
rit 0.03466796875
is 0.014404296875
, 0.04486083984375
▁and 1.583984375
▁so 0.75341796875
▁on 0.032073974609375
. 0.04931640625
▁The 1.8642578125
▁third 7.203125
▁measure 4.05078125
▁of 2.08203125
▁the 0.9794921875
▁question 2.744140625
naire 0.2139892578125
▁was 0.9853515625
▁indicated 9.8125
▁by 0.60693359375
▁information 6.66796875
▁on 1.619140625
▁any 5.34765625
▁twelve 13.6015625
- 1.2333984375
month 0.36279296875
▁and 5.8515625
▁lifetime 3.283203125
▁drug 4.671875
▁and 3.5625
▁alco 0.082275390625
hol 0.0002608299255371094
▁consumption 2.6015625
. 0.458251953125
▁In 3.505859375
▁addition 0.79541015625
, 0.12548828125
▁the 1.1328125
▁record 7.92578125
▁included 1.7294921875
▁a 2.484375
▁pain 6.31640625
▁measurement 4.3046875
▁scale 1.0556640625
▁from 3.6015625
▁ 0.442138671875
0 0.440673828125
▁to 0.479248046875
▁ 0.0080108642578125
1 0.08221435546875
0 0.06866455078125
▁to 4.58203125
▁evaluate 1.4833984375
▁dis 5.9609375
com 0.1884765625
fort 0.0031757354736328125
▁feelings 7.33984375
▁during 3.302734375
▁the 0.9111328125
▁last 1.48828125
▁month 1.4619140625
. 0.291748046875
<0x0A> 1.134765625
Am 6.96875
ong 0.0166168212890625
▁all 2.302734375
▁participants 1.8603515625
▁in 3.60546875
▁the 0.1749267578125
▁study 0.39794921875
, 0.057647705078125
▁ 0.65673828125
4 1.73046875
2 2.783203125
. 1.85546875
2 2.3125
% 0.15478515625
▁suffered 4.96875
▁from 0.130615234375
▁de 1.74609375
pression 0.1802978515625
, 1.0625
▁and 1.7666015625
▁ 0.1463623046875
3 1.71875
7 2.234375
% 2.728515625
▁experienced 2.232421875
▁excess 7.81640625
ive 0.085205078125
▁anx 0.246826171875
iety 0.0033779144287109375
. 0.349853515625
▁The 1.4169921875
▁pl 11.1328125
ur 1.03125
ality 0.0004744529724121094
▁of 0.194580078125
▁de 3.556640625
press 1.23828125
ive 0.0252227783203125
▁dis 1.84375
orders 0.060577392578125
▁among 3.806640625
▁patients 1.21484375
▁in 3.640625
▁the 0.373291015625
▁op 1.57421875
i 0.80029296875
ates 0.006763458251953125
, 7.078125
▁medical 2.806640625
▁mar 0.0218658447265625
iju 0.010528564453125
ana 0.00013744831085205078
, 0.12237548828125
▁and 0.062286376953125
▁mixed 6.0625
▁OP 8.5078125
MM 7.0
▁groups 0.505859375
▁number 8.0703125
ed 0.01229095458984375
▁ 0.11590576171875
5 2.181640625
7 2.490234375
. 0.20361328125
1 2.375
%, 0.2437744140625
▁ 0.00489044189453125
2 3.009765625
2 2.447265625
. 0.1060791015625
3 2.228515625
%, 0.124755859375
▁and 0.033416748046875
▁ 0.003498077392578125
5 3.197265625
1 2.5703125
. 0.1776123046875
4 2.1484375
%, 0.38037109375
▁resp 8.390625
E 5.9765625
ct 0.027130126953125
ively 0.130859375
. 0.31591796875
▁The 1.4072265625
▁pl 4.76953125
ur 0.03045654296875
ality 0.00014400482177734375
▁of 0.041168212890625
▁anx 0.951171875
iety 0.0202484130859375
▁contained 11.21875
▁ 0.57861328125
4 1.5830078125
8 2.375
. 0.063232421875
4 2.298828125
% 0.501953125
▁among 1.55078125
▁OP 6.67578125
▁patients 9.265625
, 0.25634765625
▁ 0.1064453125
2 1.5634765625
1 2.419921875
. 0.1375732421875
5 2.408203125
% 0.0135040283203125
▁among 0.406982421875
▁MM 0.327392578125
▁patients 0.27197265625
, 0.0139923095703125
▁and 0.0199737548828125
▁ 0.0330810546875
3 1.2333984375
8 2.626953125
. 0.1409912109375
7 2.27734375
% 0.0166168212890625
▁am 8.640625
O 2.841796875
ng 0.93310546875
▁OP 4.4921875
MM 0.10211181640625
▁participants 2.677734375
. 0.1695556640625
▁Pat 5.953125
ients 0.021820068359375
▁who 2.435546875
▁took 2.95703125
▁strong 8.3046875
▁op 1.1396484375
i 1.5087890625
ates 0.00705718994140625
▁were 1.791015625
▁t 8.4453125
ended 1.443359375
▁to 0.0185089111328125
▁place 10.34375
▁their 3.7578125
▁pain 2.744140625
▁on 3.462890625
▁a 0.81884765625
▁scale 2.37890625
▁of 0.65380859375
▁ 0.322509765625
9 2.869140625
▁to 1.392578125
▁ 0.0182037353515625
1 0.0261077880859375
0 0.08258056640625
▁( 2.6171875
Fe 1.8603515625
ing 0.0240020751953125
old 0.0031909942626953125
▁et 0.0309600830078125
▁al 0.004856109619140625
., 0.009796142578125
▁ 0.00313568115234375
2 0.0007762908935546875
0 0.0002300739288330078
1 0.00319671630859375
7 0.0177459716796875
). 0.07000732421875
▁They 4.62890625
▁were 1.2900390625
▁also 1.3916015625
▁an 8.7421875
gu 4.72265625
ished 0.060333251953125
▁em 8.2421875
otion 0.05487060546875
ally 0.00696563720703125
▁and 1.1337890625
▁react 6.8515625
ed 0.05072021484375
▁rad 9.28125
ically 0.044281005859375
▁neg 5.26953125
atively 0.003265380859375
▁to 0.359619140625
▁almost 5.30078125
▁all 1.22265625
▁survey 8.0390625
▁questions 0.6240234375
. 0.29150390625
▁Pat 4.19921875
ients 0.007465362548828125
▁who 1.1767578125
▁took 1.5146484375
▁only 5.59375
▁MM 0.84326171875
▁or 3.22265625
▁mixed 3.2265625
▁medic 2.779296875
ations 0.337890625
▁course 12.7421875
▁had 2.408203125
▁a 1.26171875
▁significantly 2.658203125
▁more 3.916015625
▁stable 3.5078125
▁emot 1.2431640625
ional 0.0088043212890625
▁state 0.8095703125
▁and 1.3642578125
▁cop 5.53125
ed 0.966796875
▁with 0.7236328125
▁pain 1.4599609375
▁more 1.6689453125
▁manage 6.8203125
able 2.38671875
. 0.4921875
<0x0A> 0.69091796875
One 5.19140625
▁of 0.62451171875
▁the 0.0209197998046875
▁major 2.611328125
▁limitations 2.904296875
▁is 3.91796875
▁the 0.50537109375
▁ins 4.73828125
u 0.019500732421875
ffic 2.30859375
ie 9.40625
N 3.216796875
t 3.3359375
ly 5.484375
▁high 3.5546875
▁response 2.095703125
▁rate 0.09808349609375
, 2.5390625
▁ 4.2265625
5 2.037109375
7 1.9072265625
% 2.29296875
▁instead 8.2109375
▁of 0.00931549072265625
▁ 0.77587890625
7 1.75390625
0 1.314453125
% 1.193359375
▁( 1.7333984375
Fe 0.300048828125
ing 0.0158233642578125
old 0.00568389892578125
▁et 0.007495880126953125
▁al 0.003997802734375
., 0.007472991943359375
▁ 0.00244903564453125
2 0.0006031990051269531
0 8.988380432128906e-05
1 0.0018377304077148438
7 0.0089263916015625
). 0.0552978515625
▁It 2.71484375
▁can 3.298828125
▁be 0.398193359375
▁fairly 8.4765625
▁explained 1.5693359375
▁by 0.1844482421875
▁the 0.319580078125
▁weak 8.21875
▁focus 7.27734375
▁of 0.4453125
▁respond 6.09765625
ents 0.1719970703125
▁who 3.4921875
▁have 4.1875
▁overcome 8.0234375
▁severe 2.291015625
▁pain 0.51904296875
▁sens 8.640625
ations 1.1181640625
▁and 1.2109375
▁de 4.078125
press 1.708984375
ive 0.2208251953125
▁episodes 4.18359375
. 0.60693359375
▁It 3.4140625
▁is 0.81103515625
▁not 2.66796875
▁clear 4.13671875
▁how 1.6416015625
▁to 3.64453125
▁use 5.26171875
▁these 2.99609375
▁statistics 3.591796875
, 2.51953125
▁as 1.40625
▁they 1.31640625
▁still 6.16015625
▁may 4.64453125
▁be 1.35546875
▁relevant 5.26171875
▁for 1.3974609375
▁the 1.859375
▁overall 4.49609375
▁analysis 3.138671875
. 1.033203125
